Vol 28 No 9

Not all therapies work the same in every patient, but that’s not the biggest challenge in treating mental health. This is.

Successful hospitals share the strategies they have used to reduce readmissions.

The amount of data in healthcare is growing, but that’s not necessarily translating to improved patient outcomes. Here’s why.

In response to the lack of transparency, health organizations are creating drug pricing tools that deliver patient-specific pricing. Here’s how they work.

Eastern Maine Healthcare System’s program helps up-and-coming leaders gain the skills to best situate the healthcare organization for future success

Value-based reimbursement models require different leadership to align the practice and move it forward around a team-based model of care.

A new forecast reveals an important focus point for healthcare execs in the quest to manage pharma costs.

Combat stress, PTSD, depression, anxiety, and substance use disorder are genuine, serious and treatable medical conditions. Here’s how one operator is tackling all of them.

Although the act would not prohibit manufacturers from increasing prices, it could change the pricing landscape. Here’s why.

This month’s featured exec is Deborah Feldman, president and CEO of Dayton Children’s Hospital. Here, she sheds light on how the future of healthcare is shaping up, and how value-based care, the ACA, and pediatric pain management fit in.

A lymphoma expert from the Allegheny Health Network Cancer Institute reveals the status of current and pipeline lymphoma treatments and the three new treatments healthcare executives need to keep on their radar.

An innovation director at Independence Blue Cross explores how small workspace changes can cultivate creativity at healthcare organizations.